Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $3.5 million.

  • Jaguar Health's Cash & Equivalents fell 7341.92% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 7341.92%. This contributed to the annual value of $8.0 million for FY2024, which is 2369.76% up from last year.
  • According to the latest figures from Q3 2025, Jaguar Health's Cash & Equivalents is $3.5 million, which was down 7341.92% from $2.2 million recorded in Q2 2025.
  • Over the past 5 years, Jaguar Health's Cash & Equivalents peaked at $32.2 million during Q1 2021, and registered a low of $2.2 million during Q2 2025.
  • In the last 5 years, Jaguar Health's Cash & Equivalents had a median value of $10.6 million in 2022 and averaged $11.5 million.
  • In the last 5 years, Jaguar Health's Cash & Equivalents soared by 255432.1% in 2021 and then tumbled by 8624.84% in 2025.
  • Over the past 5 years, Jaguar Health's Cash & Equivalents (Quarter) stood at $17.1 million in 2021, then plummeted by 67.93% to $5.5 million in 2022, then rose by 18.28% to $6.5 million in 2023, then increased by 23.7% to $8.0 million in 2024, then tumbled by 55.92% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q3 2025, $2.2 million for Q2 2025, and $5.7 million during Q1 2025.